🔗 Visit the ClinicalTrials.gov page for NCT02304393
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. | Immunotherapy | 2015 | 0.81 |
| 2 | Emerging therapeutic targets in metastatic progression: A focus on breast cancer. | Pharmacol Ther | 2016 | 0.79 |
| 3 | Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. | J Immunol Res | 2015 | 0.78 |